|
TXNDC15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.61949999966104E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.062760E-01 |
| Stage1-vs-Stage3 |
3.375800E-03 |
| Stage1-vs-Stage4 |
1.389150E-04 |
| Stage2-vs-Stage3 |
2.940200E-03 |
| Stage2-vs-Stage4 |
1.417670E-04 |
| Stage3-vs-Stage4 |
1.500630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.4711999941095E-10 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.098600E-01 |
| Caucasian-vs-Asian |
6.660600E-01 |
| AfricanAmerican-vs-Asian |
8.023600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.900600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
7.50380000000828E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.812200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.050810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.562400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.594800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.643200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.44699832513606E-11 |
| Classical-VS-Follicular |
3.133800E-01 |
| Classical-VS-Other |
7.919600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.79539946745899E-10 |
| Tall-VS-Other |
1.137780E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.699200E-01 |
| Follicular-VS-Normal |
1.63846713974181E-12 |
| Other-VS-Normal |
4.24980000000019E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.215550E-04 |
|
|
